SE0102404D0 - Novel immunomodulating compounds - Google Patents

Novel immunomodulating compounds

Info

Publication number
SE0102404D0
SE0102404D0 SE0102404A SE0102404A SE0102404D0 SE 0102404 D0 SE0102404 D0 SE 0102404D0 SE 0102404 A SE0102404 A SE 0102404A SE 0102404 A SE0102404 A SE 0102404A SE 0102404 D0 SE0102404 D0 SE 0102404D0
Authority
SE
Sweden
Prior art keywords
compound
relates
present
immunomodulating compounds
novel heterocyclic
Prior art date
Application number
SE0102404A
Other languages
English (en)
Inventor
Per Axel Bjoerk
Tomas Fex
Lars Olof Goeran Pettersson
Poul Soerensen
Dorthe Da Graca Thrige
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Priority to SE0102404A priority Critical patent/SE0102404D0/sv
Publication of SE0102404D0 publication Critical patent/SE0102404D0/sv
Priority to US10/179,731 priority patent/US6642249B2/en
Priority to AU2002315996A priority patent/AU2002315996B2/en
Priority to ES02746260T priority patent/ES2258150T3/es
Priority to CA002451749A priority patent/CA2451749A1/en
Priority to EP02746260A priority patent/EP1409485B1/en
Priority to CNB028132890A priority patent/CN1249063C/zh
Priority to BR0210776-7A priority patent/BR0210776A/pt
Priority to PCT/SE2002/001309 priority patent/WO2003004495A1/en
Priority to JP2003510662A priority patent/JP2005501033A/ja
Priority to AT02746260T priority patent/ATE324373T1/de
Priority to YU101603A priority patent/YU101603A/sh
Priority to HU0401204A priority patent/HUP0401204A3/hu
Priority to DE60210977T priority patent/DE60210977T2/de
Priority to PL02367637A priority patent/PL367637A1/xx
Priority to NZ530316A priority patent/NZ530316A/en
Priority to MXPA04000017A priority patent/MXPA04000017A/es
Priority to RU2004103079/04A priority patent/RU2004103079A/ru
Priority to HR20031055A priority patent/HRP20031055B1/xx
Priority to NO20035684A priority patent/NO20035684L/no
Priority to ZA200309806A priority patent/ZA200309806B/en
Priority to HK04109875A priority patent/HK1066809A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0102404A 2001-07-04 2001-07-04 Novel immunomodulating compounds SE0102404D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE0102404A SE0102404D0 (sv) 2001-07-04 2001-07-04 Novel immunomodulating compounds
US10/179,731 US6642249B2 (en) 2001-07-04 2002-06-26 Immunomodulating compounds
RU2004103079/04A RU2004103079A (ru) 2001-07-04 2002-07-02 Новые иммуномодулирующие соединения
AT02746260T ATE324373T1 (de) 2001-07-04 2002-07-02 Immunmodulierende verbindungen
YU101603A YU101603A (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds
CA002451749A CA2451749A1 (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds
EP02746260A EP1409485B1 (en) 2001-07-04 2002-07-02 Immunomodulating compounds
CNB028132890A CN1249063C (zh) 2001-07-04 2002-07-02 新颖的免疫调制性化合物
BR0210776-7A BR0210776A (pt) 2001-07-04 2002-07-02 Compostos de imunomodulação
PCT/SE2002/001309 WO2003004495A1 (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds
JP2003510662A JP2005501033A (ja) 2001-07-04 2002-07-02 新規免疫調節性化合物
AU2002315996A AU2002315996B2 (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds
ES02746260T ES2258150T3 (es) 2001-07-04 2002-07-02 Compuestos inmunomodulares.
HU0401204A HUP0401204A3 (en) 2001-07-04 2002-07-02 Novel immunomodulating heterocondensated pyrazol-3-one derivatives and pharmaceutical compositions containing them
DE60210977T DE60210977T2 (de) 2001-07-04 2002-07-02 Immunmodulierende verbindungen
PL02367637A PL367637A1 (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds
NZ530316A NZ530316A (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds
MXPA04000017A MXPA04000017A (es) 2001-07-04 2002-07-02 Novedosos compuestos de inmunomodulacion.
HR20031055A HRP20031055B1 (en) 2001-07-04 2003-12-17 Novel immunomodulating compounds
NO20035684A NO20035684L (no) 2001-07-04 2003-12-19 Immunomodulerende forbindelser
ZA200309806A ZA200309806B (en) 2001-07-04 2003-12-19 Novel immunomodulating compounds.
HK04109875A HK1066809A1 (en) 2001-07-04 2004-12-14 Novel immunomodulating compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102404A SE0102404D0 (sv) 2001-07-04 2001-07-04 Novel immunomodulating compounds

Publications (1)

Publication Number Publication Date
SE0102404D0 true SE0102404D0 (sv) 2001-07-04

Family

ID=20284743

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102404A SE0102404D0 (sv) 2001-07-04 2001-07-04 Novel immunomodulating compounds

Country Status (21)

Country Link
EP (1) EP1409485B1 (sv)
JP (1) JP2005501033A (sv)
CN (1) CN1249063C (sv)
AT (1) ATE324373T1 (sv)
AU (1) AU2002315996B2 (sv)
BR (1) BR0210776A (sv)
CA (1) CA2451749A1 (sv)
DE (1) DE60210977T2 (sv)
ES (1) ES2258150T3 (sv)
HK (1) HK1066809A1 (sv)
HR (1) HRP20031055B1 (sv)
HU (1) HUP0401204A3 (sv)
MX (1) MXPA04000017A (sv)
NO (1) NO20035684L (sv)
NZ (1) NZ530316A (sv)
PL (1) PL367637A1 (sv)
RU (1) RU2004103079A (sv)
SE (1) SE0102404D0 (sv)
WO (1) WO2003004495A1 (sv)
YU (1) YU101603A (sv)
ZA (1) ZA200309806B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081456B2 (en) * 2002-11-22 2006-07-25 Active Biotech Ab Immunomodulatory compounds
WO2004055014A1 (en) * 2002-12-16 2004-07-01 Active Biotech Ab Tetracyclic immunomodulatory compounds
PL1603917T3 (pl) * 2003-03-14 2011-12-30 Medigene Ag Związki heterocykliczne o właściwościach immunomodulujących
GB0305876D0 (en) * 2003-03-14 2003-04-16 Avidex Ltd Immuno inhibitory heterocyclic compounds
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
JPWO2005068467A1 (ja) 2004-01-14 2007-12-27 味の素株式会社 新規縮環化合物
GB0411770D0 (en) 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
DK1776366T3 (da) * 2004-08-09 2009-02-16 Medigene Ltd Immunomodulerende oxopyrazolocinnoliner som CD80-inhibitorer
CN101863903B (zh) * 2010-06-08 2014-03-12 沈阳药科大学 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用
WO2014209980A1 (en) * 2013-06-24 2014-12-31 Merck Patent Gmbh Pyrazole compounds as modulators of fshr and uses thereof
EP2883883A1 (en) 2013-12-16 2015-06-17 Cardio3 Biosciences S.A. Therapeutic targets and agents useful in treating ischemia reperfusion injury
WO2016007022A1 (en) 2014-07-08 2016-01-14 Avertana Limited Extraction of products from titanium-bearing minerals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents
GB8818895D0 (en) * 1988-08-09 1988-09-14 Boots Co Plc Therapeutic agents
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
EP0539372A1 (en) * 1990-02-02 1993-05-05 The Boots Company PLC Therapeutic agents
ID16283A (id) * 1996-03-20 1997-09-18 Astra Pharma Prod Senyawa yang berguna dibidang farmasi

Also Published As

Publication number Publication date
DE60210977D1 (de) 2006-06-01
HRP20031055B1 (en) 2008-01-31
CN1522254A (zh) 2004-08-18
HUP0401204A2 (hu) 2004-10-28
DE60210977T2 (de) 2006-09-21
NO20035684D0 (no) 2003-12-19
ZA200309806B (en) 2004-12-20
YU101603A (en) 2006-05-25
ATE324373T1 (de) 2006-05-15
JP2005501033A (ja) 2005-01-13
NO20035684L (no) 2004-03-02
PL367637A1 (en) 2005-03-07
CA2451749A1 (en) 2003-01-16
HUP0401204A3 (en) 2008-03-28
HK1066809A1 (en) 2005-04-01
EP1409485A1 (en) 2004-04-21
MXPA04000017A (es) 2004-05-21
AU2002315996B2 (en) 2007-11-29
HRP20031055A2 (en) 2004-06-30
BR0210776A (pt) 2004-07-20
WO2003004495A1 (en) 2003-01-16
EP1409485B1 (en) 2006-04-26
CN1249063C (zh) 2006-04-05
NZ530316A (en) 2004-08-27
RU2004103079A (ru) 2005-06-10
ES2258150T3 (es) 2006-08-16

Similar Documents

Publication Publication Date Title
HK1086562A1 (en) Pyrazoloquinolines with immunomodulating activity
HK1067120A1 (en) Glutaminyl based dpiv inhibitors
MX2021001433A (es) Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa.
BR0311343A (pt) Derivados de piridazina
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
SE0102404D0 (sv) Novel immunomodulating compounds
WO2008045393A3 (en) Imidazo- and triazolo-pyridine compounds and methods of use therof
WO2004074244A3 (en) Pyrimidine compounds
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
BR0306566B1 (pt) mÉtodo para fabricar escària contendo àxido de titÂnio.
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
WO2005068468A3 (en) Heterocyclic protein kinase inhibitors and uses thereof
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HK1061846A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
SE0200919D0 (sv) Chemical compounds
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
HUP0500136A2 (hu) Oxitocin antagonista hatású szubsztituált diketo-piperazinok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2005009951A3 (en) Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
MXPA05007607A (es) Inhibidores amida y ester de la metaloproteinasa de matriz.
WO2004007664A3 (en) Nucleic acid vectors
NO20055752L (no) N-ureidoalkyl-piperidiner som modulerer forbindelser av kjemokinreseptor-aktivitet
WO2006079720A8 (fr) Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants
ATE425164T1 (de) Tetrazyklische immunmodulierende verbindungen
HK1061845A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
GB0412314D0 (en) Compounds